Condition
Stage I Hepatocellular Carcinoma AJCC v8
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
P 2 (3)
Trial Status
Terminated1
Withdrawn1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04721132Phase 2Active Not Recruiting
Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer
NCT04805788Phase 2Terminated
Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer
NCT05157451Phase 2Withdrawn
Y-90 Versus SBRT for Inoperable HCC
Showing all 3 trials